Safety and efficacy of valsartan versus enalapril in heart failure patients.
(2002) In International Journal of Cardiology 85(2-3). p.261-270
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/114950
- author
- Willenheimer, Ronnie LU ; Helmers, Claes ; Pantev, Emil LU ; Rydberg, Erik LU ; Löfdahl, Per and Gordon, Allan
- organization
- publishing date
- 2002
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Aged, Double-Blind Method, Enalapril: adverse effects, Enalapril: therapeutic use, Female, Heart Failure, Comparative Study, Angiotensin-Converting Enzyme Inhibitors: therapeutic use, 80 and over, Analysis of Variance, Angiotensin-Converting Enzyme Inhibitors: adverse effects, Congestive: drug therapy, Human, Male, Middle Age, Receptors, Angiotensin: antagonists & inhibitors, Support, Non-U.S. Gov't, Tetrazoles: adverse effects, Tetrazoles: therapeutic use, Treatment Outcome, Valine: adverse effects, Valine: analogs & derivatives, Valine: therapeutic use
- in
- International Journal of Cardiology
- volume
- 85
- issue
- 2-3
- pages
- 261 - 270
- publisher
- Elsevier
- external identifiers
-
- pmid:12208593
- wos:000178199000011
- scopus:0036773950
- ISSN
- 0167-5273
- DOI
- 10.1016/S0167-5273(02)00154-7
- language
- English
- LU publication?
- yes
- additional info
- The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Internal Medicine (013242500), Cardiology (013230026), Emergency medicine/Medicine/Surgery (013240200)
- id
- 81d23182-3c66-4400-b57a-3d33f64ecc75 (old id 114950)
- alternative location
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12208593&dopt=Abstract
- date added to LUP
- 2016-04-01 11:40:49
- date last changed
- 2022-01-26 08:39:17
@article{81d23182-3c66-4400-b57a-3d33f64ecc75, author = {{Willenheimer, Ronnie and Helmers, Claes and Pantev, Emil and Rydberg, Erik and Löfdahl, Per and Gordon, Allan}}, issn = {{0167-5273}}, keywords = {{Aged; Double-Blind Method; Enalapril: adverse effects; Enalapril: therapeutic use; Female; Heart Failure; Comparative Study; Angiotensin-Converting Enzyme Inhibitors: therapeutic use; 80 and over; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors: adverse effects; Congestive: drug therapy; Human; Male; Middle Age; Receptors; Angiotensin: antagonists & inhibitors; Support; Non-U.S. Gov't; Tetrazoles: adverse effects; Tetrazoles: therapeutic use; Treatment Outcome; Valine: adverse effects; Valine: analogs & derivatives; Valine: therapeutic use}}, language = {{eng}}, number = {{2-3}}, pages = {{261--270}}, publisher = {{Elsevier}}, series = {{International Journal of Cardiology}}, title = {{Safety and efficacy of valsartan versus enalapril in heart failure patients.}}, url = {{http://dx.doi.org/10.1016/S0167-5273(02)00154-7}}, doi = {{10.1016/S0167-5273(02)00154-7}}, volume = {{85}}, year = {{2002}}, }